Cassava Sciences, Inc. (SAVA)
2.05
+0.02
(+0.99%)
USD |
NASDAQ |
Feb 09, 16:00
2.045
0.00 (0.00%)
After-Hours: 20:00
Cassava Sciences Total Liabilities (Quarterly) : 48.16M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| cbdMD, Inc. | 3.194M |
| BioMarin Pharmaceutical, Inc. | 1.558B |
| Amicus Therapeutics, Inc. | 638.39M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Ovid Therapeutics, Inc. | 19.15M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.73M |
| Shareholders Equity (Quarterly) | 81.57M |
| Current Ratio | 2.267 |